Two Sigma Investments, LP Arcturus Therapeutics Holdings Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 17,130 shares of ARCT stock, worth $314,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,130

Previous 13,318 28.62%

Holding current value

$314,164

Previous $324,000 22.53%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $68,920 - $96,748	3,812 Added 28.62%	17,130 $397,000
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $22,937 - $41,815	-942 Reduced 6.61%	13,318 $324,000
Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $356,022 - $490,086	-11,400 Reduced 44.43%	14,260 $481,000
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $90,321 - $168,147	5,100 Added 24.81%	25,660 $809,000
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $12,720 - $18,675	500 Added 2.49%	20,560 $525,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $205,884 - $278,296	8,600 Added 75.04%	20,060 $575,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $168,691 - $274,696	11,460 New	11,460 $274,000
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $254,584 - $354,036	-7,444 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $8.87 Million - $18.5 Million	-318,049 Reduced 97.71%	7,444 $356,000
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $1.73 Million - $2.83 Million	-67,210 Reduced 17.11%	325,493 $11 Million
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $8.9 Million - $20 Million	229,613 Added 140.79%	392,703 $16.2 Million
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $3.92 Million - $14 Million	-113,228 Reduced 40.98%	163,090 $7.08 Million
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $6.88 Million - $11.6 Million	183,572 Added 197.93%	276,318 $11.9 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $882,452 - $4.06 Million	69,704 Added 302.51%	92,746 $4.34 Million
Q1 2020 May 15, 2020	SELL	$9.31 - $18.26 $489,892 - $960,841	-52,620 Reduced 69.55%	23,042 $313,000
Q4 2019 Feb 14, 2020	BUY	$8.93 - $12.41 $543,551 - $755,371	60,868 Added 411.44%	75,662 $822,000
Q3 2019 Nov 14, 2019	BUY	$8.8 - $14.5 $130,187 - $214,513	14,794 New	14,794 $152,000

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $487M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Arcturus Therapeutics Holdings Inc. Transaction History